Post-Prescription Audit Plus Beta-D-Glucan Assessment Decrease Echinocandin Use in People with Suspected Invasive Candidiasis.

MLA

Murri, Rita, et al. “Post-Prescription Audit Plus Beta-D-Glucan Assessment Decrease Echinocandin Use in People with Suspected Invasive Candidiasis.” Medicina (Kaunas, Lithuania), vol. 57, no. 7, June 2021. EBSCOhost, https://doi.org/10.3390/medicina57070656.

APA

Murri, R., Lardo, S., De Luca, A., Posteraro, B., Torelli, R., De Angelis, G., Giovannenze, F., Taccari, F., Pavan, L., Parroni, L., Sanguinetti, M., & Fantoni, M. (2021). Post-Prescription Audit Plus Beta-D-Glucan Assessment Decrease Echinocandin Use in People with Suspected Invasive Candidiasis. Medicina (Kaunas, Lithuania), 57(7). https://doi.org/10.3390/medicina57070656

Chicago

Murri, Rita, Sara Lardo, Alessio De Luca, Brunella Posteraro, Riccardo Torelli, Giulia De Angelis, Francesca Giovannenze, et al. 2021. “Post-Prescription Audit Plus Beta-D-Glucan Assessment Decrease Echinocandin Use in People with Suspected Invasive Candidiasis.” Medicina (Kaunas, Lithuania) 57 (7). doi:10.3390/medicina57070656.